Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties

Authors :: Cseh, A
Galimard, J
de la Fuente, J
Isgro, A
Zecca, M
Garwer, B
Biffi, A
Aljurf, M
Sundin, M
Belendez, C
Locatelli, F
Balduzzi, A
Lawson, S
Sengeloev, H
Ifversen, M
Saccardi, R
Wynn, R
Lankester, A
Corbacioglu, S
Peters, C
Cseh A.
Galimard J. -E.
de la Fuente J.
Isgro A.
Zecca M.
Garwer B.
Biffi A.
Aljurf M.
Sundin M.
Belendez C.
Locatelli F.
Balduzzi A.
Lawson S.
Sengeloev H.
Ifversen M.
Saccardi R.
Wynn R.
Lankester A. C.
Corbacioglu S.
Peters C.
Cseh, A
Galimard, J
de la Fuente, J
Isgro, A
Zecca, M
Garwer, B
Biffi, A
Aljurf, M
Sundin, M
Belendez, C
Locatelli, F
Balduzzi, A
Lawson, S
Sengeloev, H
Ifversen, M
Saccardi, R
Wynn, R
Lankester, A
Corbacioglu, S
Peters, C
Cseh A.
Galimard J. -E.
de la Fuente J.
Isgro A.
Zecca M.
Garwer B.
Biffi A.
Aljurf M.
Sundin M.
Belendez C.
Locatelli F.
Balduzzi A.
Lawson S.
Sengeloev H.
Ifversen M.
Saccardi R.
Wynn R.
Lankester A. C.
Corbacioglu S.
Peters C.
Publication Year :: 2024

Tools